The shots would be the first vaccines available against a respiratory virus that kills thousands and leads to many more hospitalizations each year.
Tag: Guillain-Barre Syndrome
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
Guillain-Barré Syndrome and the Johnson & Johnson Vaccine: What to Know
The link between the rare neurological disorder and the Johnson & Johnson Covid-19 vaccine may be real, but the risk appears to be very small.